You are viewing the public part of the archive. Login or request access to view more content.
Displaying 1-8 of 8 results
01:43:46
2012_27
XIX International AIDS Conference. Session on Pediatrics with medical doctors and scientists discussing prevention of mother-to-child transmission and the development of antiretroviral treatments suitable for infants and small children.
2012_27
00:16:51
2008_84_05
XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.
2008_84_05
00:16:39
2008_82_02
XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.
2008_82_02
00:23:50
America and AIDS
This film tells the US story of the AIDS epidemic starting in the early 1980's. Scientists and activists, both pioneers and youths of today, talk about research, prevention, treatment and care. They also discuss stigma, homophobia and poverty as closely related to HIV and AIDS.
2007_america_and_aids_edited
00:19:04
2003_8_01
French virologist and Nobel Prize winner Luc Montagnier reflects on the discovery of HIV, discusses disappointments and lessons learned along the way and the possibility of a vaccine, and gives advice for future AIDS researchers.
2003_8_01
00:12:54
1994_2 (excerpt)
Joep Lange discusses his views on antiretroviral drugs, both in the developing and the developed world, future improvements of HIV drugs and treatment, and a possible vaccine.
1994_2_edited
00:12:54
1994_2
Joep Lange discusses his views on antiretroviral drugs, both in the developing and the developed world, future improvements of HIV drugs and treatment, and a possible vaccine.
1994_2
00:12:27
1988_105
Dr Luc Montagnier and Dr Lars Olof Kallings in Montagnier’s office and laboratory at the Pasteur Institute in Paris. They talk about the HIV virus and the difficulties and possibilities of finding effective antiretroviral drug combinatoions in the future.
1988_105